14 July 2020 in Biotechnology and Bioengineering
Chinese hamster ovary (CHO) cells produce a large share of today's biopharmaceuticals. Still, the generation of satisfactory producer cell lines is a tedious undertaking. Recently, it was found that CHO cells, when exposed to new environmental conditions, modify their epigenome, suggesting that cells adapt their gene expression pattern to handle new challenges. The major aim of the present study was to employ artificially induced, random changes in the DNA‐methylation pattern of CHO cells to diversify cell populations and consequently increase the finding of cell lines with improved cellular characteristics. To achieve this, DNA methyltransferases and/or the ten‐eleven translocation enzymes were downregulated by RNA interference over a time span of ∼16 days. Methylation analysis of the resulting cell pools revealed that the knockdown of DNA methyltransferases was highly effective in randomly demethylating the genome. The same approach, when applied to stable CHO producer cells resulted in (a) an increased productivity diversity in the cell population, and (b) a higher number of outliers within the population, which resulted in higher specific productivity and titer in the sorted cells. These findings suggest that epigenetics play a previously underestimated, but actually important role in defining the overall cellular behavior of production clones.
7 April 2023 in Biotechnology and Bioengineering
The insect cell‐baculovirus expression vector system (IC‐BEVS) has shown to be a powerful platform to produce complex biopharmaceutical products, such as recombinant proteins and virus‐like particles. More recently, IC‐BEVS has also been used as an alternative to produce recombinant adeno‐associated virus (rAAV). However, little is known about the variability of insect cell populations and the potential effect of heterogeneity (e.g., stochastic infection process and differences in infection kinetics) on product titer and/or quality. In this study, transcriptomics analysis of Sf9 insect cells during the production of rAAV of serotype 2 (rAAV2) using a low multiplicity of infection, dual‐baculovirus system was performed via single‐cell RNA‐sequencing (scRNA‐seq). Before infection, the principal source of variability in Sf9 insect cells was associated with the cell cycle. Over the course of infection, an increase in transcriptional heterogeneity was detected, which was linked to the expression of baculovirus genes as well as to differences in rAAV transgenes (rep, cap and gfp) expression. Noteworthy, at 24 h post‐infection, only 29.4% of cells enclosed all three necessary rAAV transgenes to produce packed rAAV2 particles, indicating limitations of the dual‐baculovirus system. In addition, the trajectory analysis herein performed highlighted that biological processes such as protein folding, metabolic processes, translation, and stress response have been significantly altered upon infection. Overall, this work reports the first application of scRNA‐seq to the IC‐BEVS and highlights significant variations in individual cells within the population, providing insight into the rational cell and process engineering toward improved rAAV2 production in IC‐BEVS.
28 May 2025 in Journal of Chemical Technology & Biotechnology
BACKGROUND: Adeno‐Associated Virus vectors are widely used in gene therapy due to their safety and efficacy. Despite the interest in their therapeutical application, AAV purification remains a significant challenge. Density gradient ultracentrifugation using cesium chloride, sucrose, or iodixanol gradients are common methods for AAV purification and polishing. However, when conventional ultracentrifuges are used, density gradient ultracentrifugation is not scalable and time‐consuming. To overcome these limitations, this study applies density gradient ultracentrifugation using a continuous flow ultracentrifuge which allows the development of scalable and robust AAV purification methods. RESULTS: Our results showed that continuous flow ultracentrifugation with both iodixanol and sucrose density gradients is a suitable method for AAV capture. Sucrose density gradient allowed for the recovery of 72% full AAV particles, however, poor resolution of full and empty AAV particles and co‐purification of host cell derived impurities were observed. Iodixanol density gradient allowed for the recovery of 68% full AAV particles as well as enrichment of full AAV particles in the higher density fractions. Moreover, separation of AAV particles from host cell derived impurities was achieved with the iodixanol density gradient. Nevertheless, chromatin fragments were still present. CONCLUSIONS: The findings of this study highlight the possibility of development of scalable AAV capture methods based on density gradient ultracentrifugation using continuous flow ultracentrifuges. © 2025 The Author(s). Journal of Chemical Technology and Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry (SCI).
9 July 2026 in Biotechnology Journal
Recombinant adeno‐associated virus (rAAV) vectors have become the leading platform for in vivo gene delivery, yet their industrial‐scale production remains inefficient and costly. Current manufacturing, which primarily relies on transient triple‐plasmid transfection in HEK293‐derived cells, is limited by low vector yields, high empty‐to‐full capsid ratios, and pronounced batch‐to‐batch variability. To contribute to the understanding of underlying host factors, we compared transcriptomic profiles of five HEK293‐derived producer lines with varying rAAV yields over a 72‐hour production time course. The low‐producing BalCD line showed poor transfection efficiency, reduced plasmid‐derived transcript levels, exclusive interferon expression and a rapid activation of interferon‐stimulated genes (ISG), indicating strong antiviral restriction for vector productivity. In contrast, high‐producing lines mounted a reduced inflammatory and innate immune response with limited induction of antiviral genes, supporting sustained vector production. Expression patterns of high‐producing cell lines further exhibited transcriptional signatures resembling those seen for producer cells arrested in the G0/G1 cell cycle phase, which potentially favors efficient vector genome replication and capsid assembly. The observed differences in the regulation of antiviral and cell cycle–associated pathways highlight key molecular determinants of rAAV productivity and provide a foundation for targeted host engineering strategies aimed at enhancing rAAV manufacturing efficiency.